1)  L02 cells
人胚胎肝细胞
1.
Purpose To study the protective effect of oligochitosan on injury induced by ethanol in human embryonic hepatocytes(L02 cells).
目的研究壳寡糖减弱乙醇对人胚胎肝细胞(L02细胞)损伤的原因。
2)  human-derived fetal hepatocytes
人胚胎肝细胞株
1.
BACKGROUND&AIM: To study the effect of3-chloro-4-(dichloromethyl)-5-hydroxy-2[5H]-furanone(MX)on proliferation and apoptosis of human-derived fetal hepatocytes(L-02)cells.
背景与目的:研究饮水氯化消毒副产物3_氯_4_二氯甲基_5_羟基_2(5氢)_呋喃酮(3_chloro_4_(dichloromethyl)_5_hydroxy_2[5H]_Furanone,MX)对人胚胎肝细胞株(Humanderivedf etalhepatocytes,L_02)增殖周期和凋亡的影响。
3)  human embryo
人胚
1.
Expression of neurotrophin-3 and its receptor in brain of human embryo during the early development;
神经营养素3和受体在早期人胚脑发育中的定位表达
2.
Isolation culture and identification of human neural stem cells from human embryos;
人胚神经干细胞的分离培养和鉴定
3.
Effects of homocysteine,homocysteine induced gene antibody and folic acid on HCY-2 expression and proliferation of human embryo cardiac myocytes;
同型半胱氨酸、同型半胱氨酸诱导基因抗体及叶酸对人胚心肌细胞同型半胱氨酸诱导基因的表达及细胞增殖的影响
4)  Human fetus
人胚
5)  Human embryo
人胚胎
1.
Effect of TSPG on proliferation and differentiation of human embryonic neural stem cell into dopaminergic neuron;
人参总皂苷对人胚胎神经干细胞增殖及定向诱导为多巴胺能神经元的影响
2.
Expression of Cx43 in esophageal epithelium of early developing human embryo;
Cx43在人胚胎早期食管上皮组织中的表达
3.
The expression and significance of Bcl-2 and Bax proteins in the early stage of the development of the spinal cord in human embryos;
Bcl-2和Bax蛋白在人胚胎早期脊髓发育中的表达及意义
6)  Human fetus
人胚胎
1.
Methods Immunohistochemical method was used to study the CgA IR cells of small intestine in 40 freshly aborted human fetuses aging from the 6th to 38th week.
目的 探讨人胚胎小肠嗜铬素A免疫反应 (CgA IR)细胞的形态学发生、发育规律。
2.
Objective:To explore the process of genesis and development of long bone of human fetus.
目的 探讨人胚胎长骨的发生及发育过程。
3.
Methods Human skin was taken from the early, middle and late human fetus respectively.
结果 人胚胎 12周表皮已表达K14 ,中期表达量最高 ,晚期也有较高表达 ,但主要局限于表皮基底层细胞。
参考词条
补充资料:肝复肽 ,肝细胞水解物
药物名称:肝复肽

英文名:Hepatocyte Hydrolysate

别名: 肝复肽 ,肝细胞水解物
外文名:hepatocyte hydrohysate
适应症: 重症肝炎、急性肝炎、慢性肝炎、肝硬化的辅助治疗。
用量用法: 肌肉注射:20 mg bid,一个月为一疗程。静脉注射:40-80mg qd,一个月为一疗程。
规格: 粉剂 20 mg x 5支。


类别:肝胆疾病辅助用药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。